Versor Investments’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
– Sell
-405,945
Closed -$16M – 877
2023
Q2
$16M Buy
+405,945
New +$14.3M 2.77% 7

Versor Investments's ISEE Position: Q3 2023 in Review

Versor Investments sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q3 2023, closing a stake of 405,945 shares — an estimated $16M sold.

Versor Investments first reported a position in ISEE in Q2 2023 and held it in 1 quarter. The position peaked at $16M in Q2 2023. 0 funds tracked by Wall St. Rank hold ISEE as of Q3 2023.

  • Versor Investments reported no remaining IVERIC bio, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Versor Investments sold 405,945 IVERIC bio, Inc. Common Stock shares in Q3 2023, an estimated $16M.
  • Versor Investments first reported a position in IVERIC bio, Inc. Common Stock in Q2 2023 and held it in 1 quarter.
  • Versor Investments's IVERIC bio, Inc. Common Stock position peaked at $16M in Q2 2023.
  • 0 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q3 2023.

Based on Versor Investments's 13F filing for Q3 2023, filed 6 Nov 2023.